Express Pharma

SMS Pharma gets US FDA approval for Andhra unit


The US FDA conducted plant inspection in the third week of April 2015

SMS Pharmaceuticals has received approval from the US FDA for its Andhra Pradesh-based manufacturing facility for its manufacturing facility located at Kandivalasa village in Vizianagaram district of Andhra Pradesh, SMS Pharmaceuticals said in a regulatory filing.

The USFDA had conducted inspection of the plant in the third week of April 2015, it added.

SMS Pharmaceuticals is engaged in manufacturing of active pharmaceutical ingredients (API) and currently has four production facilities and two research centers in operation.

Comments are closed.